Simple jQuery Dropdowns

Browsing by Author UCSF Benioff Children's Hospital Oakland

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 4 to 6 of 6 < previous 
Issue DateTitleAuthor(s)
1-Apr-2011A phase 1 dose-escalation study: Safety, tolerability, and pharmacokinetics of FBS0701, a novel oral iron chelator for the treatment of transfusional iron overloadHugh Young Rienhoff; Vip Viprakasit; Lay Tay; Paul Harmatz; Elliott Vichinsky; Deborah Chirnomas; Janet L. Kwiatkowski; Amy Tapper; William Kramer; John B. Porter; Ellis J. Neufeld; FerroKin BioSciences, Inc.; Mahidol University; Institute of Medical and Veterinary Science Australia; UCSF Benioff Children's Hospital Oakland; Children's Hospital Boston; The Children's Hospital of Philadelphia; UCL
5-Apr-2012A phase 2 study of the safety, tolerability, and pharmacodynamics of FBS0701, a novel oral iron chelator, in transfusional iron overloadEllis J. Neufeld; Renzo Galanello; Vip Viprakasit; Yesim Aydinok; Antonio Piga; Paul Harmatz; Gian Luca Forni; Farrukh T. Shah; Rachael F. Grace; John B. Porter; John C. Wood; Jennifer Peppe; Amber Jones; Hugh Young Rienhoff; Harvard University; Universita degli Studi di Cagliari; Mahidol University; Ege University Medical School; Scienze Cliniche e Biologiche; UCSF Benioff Children's Hospital Oakland; E.O. Ospedali Galliera; Whittington Hospital; UCL; Children's Hospital Los Angeles; FerroKin BioSciences, Inc.
1-Jul-2010Report from the killer immunoglobulin-like receptor (KIR) anthropology component of the 15th international histocompatibility workshop: Worldwide variation in the KIR loci and further evidence for the co-evolution of KIR and HLAJ. A. Hollenbach; A. Meenagh; C. Sleator; C. Alaez; M. Bengoche; A. Canossi; G. Contreras; L. Creary; I. Evseeva; C. Gorodezky; R. A. Hardie; T. Hemming Karlsen; B. Lie; M. Luo; M. Martinetti; C. Navarette; D. C.M. De Oliveira; G. Ozzella; A. Pasi; E. Pavlova; S. Pinto; L. C. Porto; P. Santos; A. Slavcev; D. Srinak; S. Tavoularis; S. Tonks; E. Trachtenberg; S. Vejbaesya; D. Middleton; UCSF Benioff Children's Hospital Oakland; Northern Ireland Histocompatibility; Instituto Nacional de Diagnostico y Referencia Epidemiologicos; Instituto Nacional de DonaciĆ³n y Trasplante (INDT; Consiglio Nazionale delle Ricerche; NHSBT; University of Oxford; University of Manitoba; Rikshospitalet-Radiumhospitalet HF; Fondazione IRCCS Policlinico San Matteo; Universidade do Estado do Rio de Janeiro; Institutu Klinicke a Experimentalni Mediciny; Centre for Histocompatibility of the Centre; Mahidol University; Canadian Blood Services; Weatherall Institute of Molecular Medicine; University of Liverpool